DINA MATTINGLY: Open Payments
NPI 1023600871 · BOISE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$461 in 27 payments from 7 companies in 2025. Trend: 2023 $72 · 2024 $270 · 2025 $461
Food & beverage: $461
| Company | Payments | Amount |
|---|---|---|
| Corium, LLC | 13 | $113 |
| AstraZeneca Pharmaceuticals LP | 1 | $111 |
| Tris Pharma Inc | 5 | $90 |
| Supernus Pharmaceuticals, Inc. | 4 | $73 |
| Collegium Pharmaceutical, Inc. | 2 | $41 |
| Janssen Pharmaceuticals, Inc | 1 | $19 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $15 |
Products named: Azstarys, FARXIGA, Dyanavel XR, Qelbree, Jornay PM, SPRAVATO.
Industry payments across ID — which companies pay providers there.
